The Future of Pharma

Pharma? Of the many quotes attributed to the French philosopher Voltaire, ... he would surely have asked what exactly I mean by the pharma industry, ...

The Future of Pharma

Author: Dr Brian D Smith

Publisher: Gower Publishing, Ltd.

ISBN: 1409450856

Page: 214

View: 370

By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications for employees, shareholders, governments and patients. This is not just caused by the economic crisis. Long before this, several distinct but related streams of evidence emerged that now point to the stalling of the pharmaceutical industry. The Future of Pharma examines the causes of the industry's potential decline and offers a convincing and rigorous analysis of the options open to it. What emerges is a landscape defined, on the one hand, by the changing marketplace of mass-market consumers, institutional healthcare systems and wealthy individuals; and on the other by the alternate sources of commercial value - innovative therapies; super-efficient processes, supply chains and operations; and closer customer relations and increasingly tailored health services. The challenges to the pharmaceutical industry now and in the medium and long-term are very significant. Brian Smith's highly readable research findings are a wake-up call and a first step forward for anyone concerned with the future of the industry; whether executive, customer, policymaker or investor.

Related Books:

The Future of Pharma
Language: en
Pages: 214
Authors: Dr Brian D Smith
Categories: Business & Economics
Type: BOOK - Published: 2012-02-01 - Publisher: Gower Publishing, Ltd.

By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications
Basics of Regulatory Affairs for Pharma Professional
Language: en
Pages:
Authors: Dr. Jayesh Dhalani
Categories: Business & Economics
Type: BOOK - Published: - Publisher: Lulu.com

Books about Basics of Regulatory Affairs for Pharma Professional
Big Pharma
Language: en
Pages: 266
Authors: Jacky Law
Categories: Bioethics
Type: BOOK - Published: 2006 - Publisher: Robinson

Pharmaceutical medicine is very, very big business. The top ten players earned more than $200 billion in 2003. One drug, Pfizer's cholesterol pill Lipitor, had sales of more than $9 billion. This kind of money buys an awful lot of friends among doctors and politicians. Most of those involved in
The Future of Pharma
Language: en
Pages: 214
Authors: Brian D. Smith
Categories: Business & Economics
Type: BOOK - Published: 2016-03-16 - Publisher: Routledge

By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications
Pharmaceutical Inhalation Aerosol Technology, Third Edition
Language: en
Pages: 730
Authors: Anthony J. Hickey, Sandro R. da Rocha
Categories: Medical
Type: BOOK - Published: 2019-03-26 - Publisher: CRC Press

This fully revised and updated third edition of Pharmaceutical Inhalation Aerosol Technology encompasses the scientific and technical foundation for the rationale, design, componentry, assembly and quality performance metrics of therapeutic inhalers in their delivery of pharmaceutical aerosols to treat symptoms or the underlying causes of disease. It focuses on the